Jump to ContentJump to Main Navigation
5-Hydroxytryptamine in PsychiatryA Spectrum of Ideas$
Users without a subscription are not able to see the full content.

Merton Sandler, Alec Coppen, and Sara Harnett

Print publication date: 1991

Print ISBN-13: 9780192620118

Published to Oxford Scholarship Online: March 2012

DOI: 10.1093/acprof:oso/9780192620118.001.0001

Show Summary Details
Page of

PRINTED FROM OXFORD SCHOLARSHIP ONLINE (www.oxfordscholarship.com). (c) Copyright Oxford University Press, 2017. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a monograph in OSO for personal use (for details see http://www.oxfordscholarship.com/page/privacy-policy).date: 11 December 2017

Anxiogenic effect of the 5-HT1C agonist m-chlorophenylpiperazine

Anxiogenic effect of the 5-HT1C agonist m-chlorophenylpiperazine

Chapter:
(p.198) 16. Anxiogenic effect of the 5-HT1C agonist m-chlorophenylpiperazine
Source:
5-Hydroxytryptamine in Psychiatry
Author(s):

G. Curzon

G. A. Kennett

P. Whitton

Publisher:
Oxford University Press
DOI:10.1093/acprof:oso/9780192620118.003.0016

The earlier literature on l-(3-chlorophenyl)piperazine (m-CPP) and l-[3-(trifluoromethyl)phenyl] piperazine (TFMPP) describes these compounds mainly as agonists at the IB subtype of 5-hydroxytryptamine (5-HT, serotonin) receptors. However, many findings suggest that their hypolocomotor and hypophagic effects are mediated by stimulation of 5-HTlc receptors. As m-CPP causes anxiety in humans it was investigated whether m-CPP and TFMPP had anxiogenic-like effects in rats. The results indicate that this occurs and is mediated by hippocampal 5-HTlc receptors.

Keywords:   hypolocomotor, TFMPP, m-chlorophenylpiprazine, trifluoromethylphenyl piprazine, anxiogenic, 5-hydroxytryptamine

Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .